Mycophenolate mofetil Recruiting Phase 2 Trials for Scleroderma / Sclerosis, Progressive Systemic / Interstitial Lung Disease (ILD) Treatment

IndicationsStatusPurposePhase
RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT02370693Comparing and Combining Bortezomib and Mycophenolate in SSc Pulmonary Fibrosis
NCT03844061Belimumab and Rituximab Combination Therapy for the Treatment of Diffuse Cutaneous Systemic Sclerosis